Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Provectus Biopharmaceuticals - 30 Year Stock Price History | PVCT

Historical daily share price chart and data for Provectus Biopharmaceuticals since 1995 adjusted for splits and dividends. The latest closing stock price for Provectus Biopharmaceuticals as of November 14, 2025 is 0.06.
  • The all-time high Provectus Biopharmaceuticals stock closing price was 8437.50 on June 16, 2000.
  • The Provectus Biopharmaceuticals 52-week high stock price is 0.15, which is 150% above the current share price.
  • The Provectus Biopharmaceuticals 52-week low stock price is 0.06, which is 0% below the current share price.
  • The average Provectus Biopharmaceuticals stock price for the last 52 weeks is 0.09.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Provectus Biopharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.0878 0.1204 0.1204 0.0580 0.0649 -45.96%
2024 0.1346 0.1048 0.2169 0.0844 0.1201 25.10%
2023 0.1204 0.1189 0.1745 0.0650 0.0960 -11.36%
2022 0.0637 0.0650 0.1832 0.0400 0.1083 96.91%
2021 0.0650 0.0551 0.0830 0.0474 0.0550 -5.82%
2020 0.0613 0.0620 0.0989 0.0315 0.0584 -7.89%
2019 0.0603 0.0530 0.0720 0.0425 0.0634 26.80%
2018 0.0714 0.0840 0.0900 0.0500 0.0500 -39.02%
2017 0.0345 0.0192 0.0820 0.0165 0.0820 318.37%
2016 0.2617 0.4090 0.5175 0.0116 0.0196 -94.97%
2015 0.6539 0.8510 0.9222 0.3800 0.3900 -51.25%
2014 1.4708 2.7200 5.2200 0.5520 0.8000 -66.80%
2013 0.7773 0.6100 2.4980 0.5502 2.4100 330.36%
2012 0.7671 0.8600 0.9800 0.5200 0.5600 -30.86%
2011 0.9360 0.9500 1.1600 0.6800 0.8100 -13.83%
2010 1.1006 0.9200 1.6750 0.8400 0.9400 3.30%
2009 0.9985 0.9300 1.2800 0.8400 0.9100 -1.09%
2008 1.1544 1.5900 1.6400 0.7400 0.9200 -46.51%
2007 1.7239 1.1800 3.0000 1.1000 1.7200 44.54%
2006 1.1826 0.9300 1.9700 0.8300 1.1900 32.22%
2005 0.8294 0.6700 1.2100 0.5300 0.9000 36.36%
2004 1.0160 1.1500 1.7000 0.4700 0.6600 -34.65%
2003 0.6499 0.3000 1.4000 0.2000 1.0100 260.71%
2002 61.5882 750.0000 750.0000 0.0700 0.2800 -99.96%
2001 509.8393 600.0000 825.0000 300.0000 630.0000 20.00%
2000 1551.2171 1800.0000 8437.5000 90.0000 525.0000 0.00%
1997 90.0000 90.0000 90.0000 90.0000 90.0000 0.00%
1996 90.0000 90.0000 90.0000 90.0000 90.0000 -90.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.027B $0.001B
Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. The company's product portfolio consists of PV-10 Melanoma, PH-10 Psoriasis, PH-10 Atopic Dermatitis, PV-10 Breast Cancer, PV-10 Liver Metastasis and PV-10 Mechanism of Action which are in clinical trials. Provectus Biopharmaceuticals Inc., formerly known as Provectus Pharmaceuticals, Inc., is based in Knoxville, Tennessee.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $274.815B 19.39
Amgen (AMGN) United States $180.930B 15.36
Gilead Sciences (GILD) United States $155.333B 15.29
Vertex Pharmaceuticals (VRTX) United States $110.246B 28.38
Bristol Myers Squibb (BMY) United States $98.999B 7.41
GSK (GSK) United Kingdom $97.744B 10.87
Regeneron Pharmaceuticals (REGN) United States $73.043B 18.95
Alnylam Pharmaceuticals (ALNY) United States $59.976B 1973.78
CSL (CSLLY) Australia $56.743B 0.00
Argenex SE (ARGX) Netherlands $54.903B 68.18
Insmed (INSM) United States $40.727B 0.00
Novozymes (NVZMY) Denmark $30.566B 0.00
BioNTech SE (BNTX) Germany $24.979B 0.00
Biogen (BIIB) United States $24.166B 9.84
Royalty Pharma (RPRX) United States $22.934B 8.79
Incyte (INCY) United States $20.694B 19.81
Genmab (GNMSF) Denmark $20.087B 14.74
Genmab (GMAB) Denmark $19.416B 14.61
Illumina (ILMN) United States $18.325B 27.51
Roivant Sciences (ROIV) United Kingdom $14.040B 0.00
Exact Sciences (EXAS) United States $12.837B 356.58
Ascendis Pharma (ASND) Denmark $12.737B 0.00
Revolution Medicines (RVMD) United States $12.446B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Guardant Health (GH) United States $11.864B 0.00
Exelixis (EXEL) United States $11.355B 18.18
Avidity Biosciences (RNA) United States $10.674B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.416B 18.89
QIAGEN (QGEN) Netherlands $9.925B 18.84
Moderna (MRNA) United States $9.751B 0.00
Bio-Techne Corp (TECH) United States $9.466B 35.32
Jazz Pharmaceuticals (JAZZ) Ireland $8.611B 33.58
Repligen (RGEN) United States $8.475B 90.70
Halozyme Therapeutics (HALO) United States $8.372B 13.38
Bio-Rad Laboratories (BIO.B) United States $8.238B 29.62
Cytokinetics (CYTK) United States $8.011B 0.00
Abivax SA (ABVX) France $7.853B 0.00
Metsera (MTSR) United States $7.429B 0.00
Merus (MRUS) Netherlands $7.287B 0.00
Axsome Therapeutics (AXSM) United States $6.927B 0.00
Nuvalent (NUVL) United States $6.884B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.428B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.399B 0.00
PTC Therapeutics (PTCT) United States $6.018B 8.17
Vaxcyte (PCVX) United States $5.963B 0.00
Krystal Biotech (KRYS) United States $5.835B 30.17
Legend Biotech (LEGN) United States $5.724B 0.00
Zealand Pharma (ZLDPF) Denmark $5.717B 5.79
Arrowhead Pharmaceuticals (ARWR) United States $5.688B 0.00
Protagonist Therapeutics (PTGX) United States $5.204B 134.26
Alkermes (ALKS) Ireland $5.120B 15.05
Arcellx (ACLX) United States $5.055B 0.00
TG Therapeutics (TGTX) United States $4.915B 11.14
CRISPR Therapeutics AG (CRSP) Switzerland $4.871B 0.00
Cogent Biosciences (COGT) United States $4.817B 0.00
Kymera Therapeutics (KYMR) United States $4.578B 0.00
Akero Therapeutics (AKRO) United States $4.462B 0.00
Praxis Precision Medicines (PRAX) United States $4.453B 0.00
Viking Therapeutics (VKTX) United States $4.408B 0.00
Immunovant (IMVT) United States $4.000B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.999B 33.77
Ligand Pharmaceuticals (LGND) United States $3.961B 97.23
ADMA Biologics Inc (ADMA) United States $3.737B 26.61
Celcuity (CELC) United States $3.649B 0.00
Belite Bio (BLTE) United States $3.579B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.559B 0.00
Mineralys Therapeutics (MLYS) United States $3.505B 0.00
Anbio Biotechnology (NNNN) Germany $3.354B 0.00
Cidara Therapeutics (CDTX) United States $3.332B 0.00
Disc Medicine (IRON) United States $3.286B 0.00
Telix Pharmaceuticals (TLX) Australia $3.219B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.174B 0.00
Ascentage Pharma Group - (AAPG) China $3.143B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.094B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.079B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.054B 89.53
Travere Therapeutics (TVTX) United States $3.032B 0.00
GRAIL (GRAL) United States $2.999B 0.00
Jyong Biotech (MENS) Taiwan $2.907B 0.00
Apogee Therapeutics (APGE) United States $2.904B 0.00
Amicus Therapeutics (FOLD) United States $2.894B 234.50
Scholar Rock Holding (SRRK) United States $2.891B 0.00
CG Oncology (CGON) United States $2.879B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.800B 0.00
IDEAYA Biosciences (IDYA) United States $2.790B 0.00
Viridian Therapeutics (VRDN) United States $2.719B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.648B 0.00
Denali Therapeutics (DNLI) United States $2.515B 0.00
Apellis Pharmaceuticals (APLS) United States $2.506B 63.90
Agios Pharmaceuticals (AGIO) United States $2.481B 0.00
Zai Lab (ZLAB) China $2.429B 0.00
Liquidia (LQDA) United States $2.344B 0.00
Bavarian Nordic (BVNRY) Denmark $2.296B 11.10
Recursion Pharmaceuticals (RXRX) United States $2.254B 0.00
Beam Therapeutics (BEAM) United States $2.198B 0.00
Edgewise Therapeutics (EWTX) United States $2.162B 0.00
Adaptive Biotechnologies (ADPT) United States $2.159B 0.00
Arcus Biosciences (RCUS) United States $2.137B 0.00
Structure Therapeutics (GPCR) United States $2.016B 0.00
Vericel (VCEL) United States $2.015B 166.00
Harmony Biosciences Holdings (HRMY) United States $1.975B 10.78
ImmunityBio (IBRX) United States $1.970B 0.00
Zenas BioPharma (ZBIO) United States $1.914B 0.00
Mesoblast (MESO) Australia $1.914B 0.00
ANI Pharmaceuticals (ANIP) United States $1.900B 14.73
UniQure (QURE) Netherlands $1.890B 0.00
Terns Pharmaceuticals (TERN) United States $1.867B 0.00
Sarepta Therapeutics (SRPT) United States $1.867B 0.00
Vera Therapeutics (VERA) United States $1.811B 0.00
Twist Bioscience (TWST) United States $1.805B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.782B 0.00
Spyre Therapeutics (SYRE) United States $1.756B 0.00
Alvotech (ALVO) Luxembourg $1.664B 24.00
Janux Therapeutics (JANX) United States $1.652B 0.00
Nuvation Bio (NUVB) United States $1.608B 0.00
Sionna Therapeutics (SION) United States $1.601B 0.00
Celldex Therapeutics (CLDX) United States $1.576B 0.00
MannKind (MNKD) United States $1.557B 50.70
Maze Therapeutics (MAZE) United States $1.532B 0.00
Dianthus Therapeutics (DNTH) United States $1.522B 0.00
Immunome (IMNM) United States $1.514B 0.00
Stoke Therapeutics (STOK) United States $1.489B 38.91
Syndax Pharmaceuticals (SNDX) United States $1.448B 0.00
Trevi Therapeutics (TRVI) United States $1.396B 0.00
Zymeworks (ZYME) United States $1.384B 0.00
Certara (CERT) United States $1.339B 24.74
Dynavax Technologies (DVAX) United States $1.310B 38.48
NeoGenomics (NEO) United States $1.295B 0.00
NovoCure (NVCR) Jersey $1.274B 0.00
Pharvaris (PHVS) Netherlands $1.269B 0.00
Upstream Bio (UPB) United States $1.261B 0.00
Immatics (IMTX) Germany $1.213B 0.00
Pharming Group (PHAR) Netherlands $1.207B 0.00
CureVac (CVAC) Germany $1.189B 5.52
Oric Pharmaceuticals (ORIC) United States $1.184B 0.00
Rapport Therapeutics (RAPP) United States $1.176B 0.00
Precigen (PGEN) United States $1.150B 0.00
Novavax (NVAX) United States $1.147B 2.92
Mind Medicine (MindMed) (MNMD) United States $1.146B 0.00
Urogen Pharma (URGN) United States $1.120B 0.00
WAVE Life Sciences (WVE) Singapore $1.115B 0.00
MiMedx (MDXG) United States $1.106B 19.66
AbCellera Biologics (ABCL) Canada $1.084B 0.00
Inhibrx Biosciences (INBX) United States $1.081B 0.00
MBX Biosciences (MBX) United States $1.081B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.056B 0.00
Tango Therapeutics (TNGX) United States $1.039B 0.00
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Pacira BioSciences (PCRX) United States $1.016B 11.64
Oculis Holding AG (OCS) Switzerland $1.010B 0.00
Intellia Therapeutics (NTLA) United States $1.004B 0.00
Kodiak Sciences (KOD) United States $0.997B 0.00
Castle Biosciences (CSTL) United States $0.996B 136.48
BridgeBio Oncology Therapeutics (BBOT) United States $0.990B 0.00
Sana Biotechnology (SANA) United States $0.975B 0.00
Nanobiotix S.A - (NBTX) France $0.972B 0.00
Iovance Biotherapeutics (IOVA) United States $0.957B 0.00
Nurix Therapeutics (NRIX) United States $0.956B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.953B 0.00
Palvella Therapeutics (PVLA) United States $0.953B 0.00
Fortrea Holdings (FTRE) United States $0.944B 20.04
Monte Rosa Therapeutics (GLUE) United States $0.932B 44.75
Kura Oncology (KURA) United States $0.929B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Rezolute (RZLT) United States $0.922B 0.00
AnaptysBio (ANAB) United States $0.921B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.909B 0.00
BGM Group (BGM) China $0.893B 0.00
CorMedix Inc (CRMD) United States $0.883B 8.18
Arbutus Biopharma (ABUS) United States $0.874B 0.00
Septerna (SEPN) United States $0.861B 0.00
Biohaven (BHVN) United States $0.855B 0.00
Compass Therapeutics (CMPX) United States $0.848B 0.00
Tyra Biosciences (TYRA) United States $0.832B 0.00
LENZ Therapeutics (LENZ) United States $0.829B 0.00
ArriVent BioPharma (AVBP) United States $0.812B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $0.807B 0.00
Bicara Therapeutics (BCAX) United States $0.781B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.781B 0.00
Gyre Therapeutics (GYRE) United States $0.778B 101.00
Rapt Therapeutics (RAPT) United States $0.770B 0.00
Vir Biotechnology (VIR) United States $0.761B 0.00
Geron (GERN) United States $0.734B 0.00
Erasca (ERAS) United States $0.721B 0.00
GH Research (GHRS) Ireland $0.714B 0.00
Astria Therapeutics (ATXS) United States $0.710B 0.00
Replimune (REPL) United States $0.704B 0.00
Ventyx Biosciences (VTYX) United States $0.681B 0.00
MeiraGTx Holdings (MGTX) United States $0.665B 0.00
CytomX Therapeutics (CTMX) United States $0.654B 9.65
Arvinas (ARVN) United States $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Prime Medicine (PRME) United States $0.601B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.597B 0.00
Myriad Genetics (MYGN) United States $0.592B 0.00
MapLight Therapeutics (MPLT) United States $0.592B 0.00
REGENXBIO (RGNX) United States $0.589B 0.00
Cytek Biosciences (CTKB) United States $0.584B 0.00
Opthea (OPT) Australia $0.583B 0.00
Gossamer Bio (GOSS) United States $0.581B 0.00
Niagen Bioscience (NAGE) United States $0.558B 43.69
Alumis (ALMS) United States $0.549B 0.00
Prothena (PRTA) Ireland $0.548B 0.00
Olema Pharmaceuticals (OLMA) United States $0.545B 0.00
Emergent Biosolutions (EBS) United States $0.542B 5.21
Verastem (VSTM) United States $0.542B 0.00
Monopar Therapeutics (MNPR) United States $0.537B 0.00
Inventiva S.A (IVA) France $0.532B 0.00
Keros Therapeutics (KROS) United States $0.527B 11.23
Lexicon Pharmaceuticals (LXRX) United States $0.523B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.502B 0.00
Anavex Life Sciences (AVXL) United States $0.489B 0.00
Cullinan Therapeutics (CGEM) United States $0.489B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.485B 0.00
NovaBridge Biosciences (NBP) United States $0.481B 0.00
Fulcrum Therapeutics (FULC) United States $0.476B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.458B 0.00
Eton Pharmaceuticals (ETON) United States $0.453B 0.00
Neumora Therapeutics (NMRA) United States $0.449B 0.00
DBV Technologies S.A (DBVT) France $0.442B 0.00
EnGene Holdings (ENGN) Canada $0.432B 0.00
Invivyd (IVVD) United States $0.413B 0.00
Bright Minds Biosciences (DRUG) United States $0.411B 0.00
Kamada (KMDA) Israel $0.407B 19.67
Design Therapeutics (DSGN) United States $0.402B 0.00
XOMA Royalty (XOMA) United States $0.399B 0.00
Absci (ABSI) United States $0.397B 0.00
PureTech Health (PRTC) United States $0.395B 0.00
Ocugen (OCGN) United States $0.387B 0.00
Neurogene (NGNE) United States $0.378B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.377B 0.00
Northwest Biotherapeutics (NWBO) United States $0.374B 0.00
Alto Neuroscience (ANRO) United States $0.353B 0.00
Benitec Biopharma (BNTC) United States $0.345B 0.00
Aura Biosciences (AURA) United States $0.344B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.343B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.341B 0.00
Amarin (AMRN) Ireland $0.338B 0.00
Entrada Therapeutics (TRDA) United States $0.336B 0.00
Solid Biosciences (SLDB) United States $0.335B 0.00
Tectonic Therapeutic (TECX) United States $0.329B 0.00
X4 Pharmaceuticals (XFOR) United States $0.326B 0.00
AC Immune (ACIU) Switzerland $0.324B 0.00
Annexon (ANNX) United States $0.321B 0.00
Contineum Therapeutics (CTNM) United States $0.318B 0.00
Jade Biosciences (JBIO) United States $0.316B 0.00
Lifecore Biomedical (LFCR) United States $0.296B 0.00
Kyverna Therapeutics (KYTX) United States $0.284B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.283B 0.00
DiaMedica Therapeutics (DMAC) United States $0.282B 0.00
Palisade Bio (PALI) United States $0.279B 0.00
BioAge Labs (BIOA) United States $0.277B 0.00
Zura Bio (ZURA) United States $0.272B 0.00
Prima BioMed (IMMP) Australia $0.271B 0.00
Allogene Therapeutics (ALLO) United States $0.270B 0.00
Immuneering (IMRX) United States $0.268B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.256B 0.00
Black Diamond Therapeutics (BDTX) United States $0.256B 12.47
Candel Therapeutics (CADL) United States $0.253B 0.00
Sagimet Biosciences (SGMT) United States $0.252B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.251B 0.00
Puma Biotechnology (PBYI) United States $0.249B 6.69
Editas Medicine (EDIT) United States $0.248B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Abeona Therapeutics (ABEO) United States $0.245B 4.01
Atea Pharmaceuticals (AVIR) United States $0.239B 0.00
Nautilus Biotechnology (NAUT) United States $0.239B 0.00
C4 Therapeutics (CCCC) United States $0.237B 0.00
Alpha Teknova (TKNO) United States $0.237B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.236B 0.00
Aardvark Therapeutics (AARD) United States $0.236B 0.00
Rani Therapeutics Holdings (RANI) United States $0.235B 0.00
Tenaya Therapeutics (TNYA) United States $0.228B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.227B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.227B 0.00
Cabaletta Bio (CABA) United States $0.225B 0.00
Voyager Therapeutics (VYGR) United States $0.221B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.221B 0.00
Adherex Technologies (FENC) United States $0.216B 0.00
Adocia (ADOCY) France $0.216B 0.00
Genelux (GNLX) United States $0.210B 0.00
GENFIT S.A (GNFT) France $0.208B 0.00
CAMP4 Therapeutics (CAMP) United States $0.200B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.193B 0.00
Humacyte (HUMA) United States $0.188B 0.00
Cartesian Therapeutics (RNAC) United States $0.188B 0.00
Caribou Biosciences (CRBU) United States $0.186B 0.00
SELLAS Life Sciences (SLS) United States $0.183B 0.00
Crescent Biopharma (CBIO) United States $0.180B 0.00
Molecular Partners AG (MOLN) Switzerland $0.173B 0.00
Forte Biosciences (FBRX) United States $0.172B 0.00
Innate Pharma S.A (IPHA) France $0.168B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.162B 0.00
MaxCyte (MXCT) United States $0.161B 0.00
PepGen (PEPG) United States $0.160B 0.00
Coherus Oncology (CHRS) United States $0.152B 0.00
Seres Therapeutics (MCRB) United States $0.152B 0.00
Nuvectis Pharma (NVCT) United States $0.152B 0.00
Sangamo Therapeutics (SGMO) United States $0.151B 0.00
Elicio Therapeutics (ELTX) United States $0.149B 0.00
Agenus (AGEN) United States $0.147B 0.00
Compugen (CGEN) Israel $0.147B 0.00
Codexis (CDXS) United States $0.147B 0.00
Anika Therapeutics (ANIK) United States $0.146B 0.00
Cardiff Oncology (CRDF) United States $0.145B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.145B 0.00
EXoZymes (EXOZ) United States $0.138B 0.00
Spero Therapeutics (SPRO) United States $0.137B 0.00
Mersana Therapeutics (MRSN) United States $0.137B 0.00
Actuate Therapeutics (ACTU) United States $0.137B 0.00
Cognition Therapeutics (CGTX) United States $0.136B 0.00
Scilex Holding (SCLX) United States $0.136B 0.00
Nkarta (NKTX) United States $0.134B 0.00
Alector (ALEC) United States $0.131B 0.00
Inovio Pharmaceuticals (INO) United States $0.130B 0.00
Alpha Cognition (ACOG) Canada $0.128B 0.00
Opus Genetics (IRD) United States $0.128B 0.00
Climb Bio (CLYM) United States $0.128B 0.00
Entera Bio (ENTX) Israel $0.125B 0.00
Coya Therapeutics (COYA) United States $0.125B 0.00
VTv Therapeutics (VTVT) United States $0.123B 0.00
Immix Biopharma (IMMX) United States $0.121B 0.00
BioHarvest Sciences (BHST) Canada $0.120B 0.00
VistaGen Therapeutics (VTGN) United States $0.117B 0.00
Shattuck Labs (STTK) United States $0.116B 0.00
Turn Therapeutics (TTRX) United States $0.115B 0.00
Fate Therapeutics (FATE) United States $0.114B 0.00
Seer (SEER) United States $0.114B 0.00
Greenwich LifeSciences (GLSI) United States $0.114B 0.00
Starpharma Holdings (SPHRY) Australia $0.113B 0.00
Citius Oncology (CTOR) United States $0.111B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.110B 0.00
Oncolytics Biotech (ONCY) Canada $0.108B 0.00
Pliant Therapeutics (PLRX) United States $0.106B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.105B 0.00
TuHURA Biosciences (HURA) United States $0.105B 0.00
Adicet Bio (ACET) United States $0.102B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.101B 0.00
Kalaris Therapeutics (KLRS) United States $0.100B 0.00
Whitehawk Therapeutics (WHWK) United States $0.099B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.097B 0.00
Atara Biotherapeutics (ATRA) United States $0.097B 6.14
Zentalis Pharmaceuticals (ZNTL) United States $0.095B 0.00
Adverum Biotechnologies (ADVM) United States $0.094B 0.00
Connect Biopharma Holdings (CNTB) United States $0.094B 0.00
Instil Bio (TIL) United States $0.094B 0.00
Quince Therapeutics (QNCX) United States $0.094B 0.00
Biomea Fusion (BMEA) United States $0.091B 0.00
OKYO Pharma (OKYO) $0.090B 0.00
Tevogen Bio Holdings (TVGN) United States $0.087B 0.00
Chrome Holding (MEHCQ) United States $0.087B 0.00
Ovid Therapeutics (OVID) United States $0.085B 0.00
InflaRx (IFRX) Germany $0.085B 0.00
Adagene (ADAG) China $0.085B 0.00
Artiva Biotherapeutics (ARTV) United States $0.083B 0.00
BeyondSpring (BYSI) United States $0.083B 0.00
Estrella Immunopharma (ESLA) United States $0.083B 0.00
XBiotech (XBIT) United States $0.081B 0.00
Sutro Biopharma (STRO) United States $0.079B 0.00
Precision BioSciences (DTIL) United States $0.078B 0.00
Fortress Biotech (FBIO) United States $0.074B 0.00
Clene (CLNN) United States $0.074B 0.00
Repare Therapeutics (RPTX) Canada $0.073B 0.00
Immunic (IMUX) United States $0.070B 0.00
ATyr Pharma (ATYR) United States $0.070B 0.00
BioStem Technologies (BSEM) $0.069B 4.87
Coeptis Therapeutics Holdings (COEP) United States $0.068B 0.00
ABVC BioPharma (ABVC) United States $0.068B 0.00
CervoMed (CRVO) United States $0.067B 0.00
Vor Biopharma (VOR) $0.067B 0.00
ALX Oncology Holdings (ALXO) United States $0.066B 0.00
Oncobiologics (OTLK) United States $0.065B 0.00
TScan Therapeutics (TCRX) United States $0.064B 0.00
MiNK Therapeutics (INKT) United States $0.061B 0.00
Annovis Bio (ANVS) United States $0.061B 0.00
Spruce Biosciences (SPRB) United States $0.057B 0.00
Adlai Nortye (ANL) Cayman Islands $0.056B 0.00
Equillium (EQ) United States $0.050B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Senti Biosciences (SNTI) United States $0.047B 0.00
CalciMedica (CALC) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
Werewolf Therapeutics (HOWL) United States $0.045B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.045B 0.00
TELA Bio (TELA) United States $0.044B 0.00
Skye Bioscience (SKYE) United States $0.044B 0.00
Grace Therapeutics (GRCE) Canada $0.043B 0.00
OnKure Therapeutics (OKUR) United States $0.043B 0.00
Celularity (CELU) United States $0.042B 0.00
Radiopharm Theranostics - (RADX) Australia $0.042B 0.00
Genenta Science S.p.A (GNTA) Italy $0.042B 0.00
Medicus Pharma (MDCX) United States $0.040B 0.00
PDS Biotechnology (PDSB) United States $0.040B 0.00
Applied Therapeutics (APLT) United States $0.039B 0.00
BioAtla (BCAB) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.039B 0.00
Tvardi Therapeutics (TVRD) United States $0.039B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.038B 0.00
INmune Bio (INMB) United States $0.038B 0.00
Generation Bio (GBIO) United States $0.038B 0.00
Aligos Therapeutics (ALGS) United States $0.037B 0.00
Galecto (GLTO) Denmark $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
RenovoRx (RNXT) United States $0.036B 0.00
Hyperion DeFi (HYPD) United States $0.035B 0.00
Pluri (PLUR) Israel $0.034B 0.00
ImageneBio (IMA) United States $0.033B 0.00
Dyadic (DYAI) United States $0.033B 0.00
Alterity Therapeutics - (ATHE) Australia $0.033B 0.00
SAB Biotherapeutics (SABS) United States $0.032B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.032B 0.00
Elutia (ELUT) United States $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Tenax Therapeutics (TENX) United States $0.031B 0.00
Quantum Biopharma (QNTM) Canada $0.029B 0.00
Intensity Therapeutics (INTS) United States $0.029B 0.00
Rallybio (RLYB) United States $0.028B 0.00
Passage Bio (PASG) United States $0.027B 0.00
Q32 Bio (QTTB) United States $0.027B 0.00
Femasys (FEMY) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.027B 0.00
Jasper Therapeutics (JSPR) United States $0.026B 0.00
NextCure (NXTC) United States $0.026B 0.00
IBio (IBIO) United States $0.026B 0.00
BioXcel Therapeutics (BTAI) United States $0.026B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.025B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.025B 0.00
Lexaria Bioscience (LEXX) Canada $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.024B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Exicure (XCUR) United States $0.023B 0.00
Apollomics (APLM) United States $0.023B 0.00
Tharimmune (THAR) United States $0.023B 0.00
Synaptogenix (TAOX) United States $0.023B 0.00
Moleculin Biotech (MBRX) United States $0.022B 0.00
Promis Neurosciences (PMN) Canada $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Synlogic (SYBX) United States $0.020B 0.00
Clearside Biomedical (CLSD) United States $0.019B 0.00
Athira Pharma (ATHA) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.018B 0.00
Lisata Therapeutics (LSTA) United States $0.018B 0.00
Cingulate (CING) United States $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
FibroBiologics (FBLG) United States $0.017B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.017B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.016B 0.00
MetaVia (MTVA) United States $0.016B 0.00
Abpro Holdings (ABP) United States $0.016B 0.00
NewcelX (NCEL) Switzerland $0.016B 0.00
Longeveron (LGVN) United States $0.015B 0.00
Curis (CRIS) United States $0.015B 0.00
Revelation Biosciences (REVB) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Chemomab Therapeutics (CMMB) Israel $0.013B 0.00
Dogwood Therapeutics (DWTX) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Beyond Air (XAIR) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biofrontera (BFRI) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.010B 0.00
Acurx Pharmaceuticals (ACXP) $0.010B 0.00
Advanced Biomed (ADVB) United States $0.010B 0.00
Gelteq (GELS) Australia $0.010B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Aprea Therapeutics (APRE) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
BRIACELL THERAP (BCTX) Canada $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Black Titan (BTTC) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
GT Biopharma (GTBP) United States $0.003B 0.00
Alps Group (ALPS) United States $0.003B 2.16
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00